Li Qin, Shen Feiyang, Wang Chenghai
Department of Clinic, School of Medicine, Yangzhou Polytechnic College, Yangzhou, Jiangsu 225009, P.R. China.
School of Medicine, Yangzhou University, Yangzhou, Jiangsu 225000, P.R. China.
Oncol Lett. 2017 Jun;13(6):4526-4532. doi: 10.3892/ol.2017.5971. Epub 2017 Apr 3.
Ultraconserved regions (UCRs) are non-protein-coding gene sequences that are strictly conserved across numerous distinct species. It has been demonstrated previously that UCRs encoding non-coding RNAs serve as regulators of gene expression. In recent decades, there has been increasing evidence for the involvement of UCRs in carcinogenesis. In previous studies, the non-coding RNA transcribed ultraconserved element 338 (TUC338) was identified to serve an oncogenic role in hepatocellular cancer; however, thus far, the role of TUC338 in cervical cancer (CC) remains undefined. The results of the present study revealed that TUC338 is significantly upregulated in CC tissues and cell lines, and that the upregulation of TUC338 is associated with lymph node metastasis. Transfection with small interfering RNA (siRNA) against TUC338 could markedly inhibit cell migration and invasion in HeLa and C33A CC cell lines. Using a dual-luciferase reporter assay, tissue inhibitor of metalloproteinase 1 (TIMP1) was demonstrated to be negatively regulated by TUC338 at the post-transcriptional level, via a specific target site within the 3' untranslated region. The expression of TIMP1 was also observed to be inversely associated with TUC338 expression in CC tissues. Overexpression of TIMP1 with MigRI-TIMP1-green fluorescent protein inhibited CC cell migration and invasion and downregulated matrix metalloproteinase 9, resembling the effects of TUC338 siRNA. Therefore, the results of the present study suggest that TUC338 acts as a novel oncogene by targeting the TIMP1 gene, and inhibiting CC cell migration and invasion.
超保守区域(UCRs)是在众多不同物种中严格保守的非蛋白质编码基因序列。先前已证明,编码非编码RNA的UCRs可作为基因表达的调节因子。近几十年来,越来越多的证据表明UCRs参与了肿瘤发生。在先前的研究中,已确定非编码RNA转录超保守元件338(TUC338)在肝细胞癌中发挥致癌作用;然而,迄今为止,TUC338在宫颈癌(CC)中的作用仍不明确。本研究结果显示,TUC338在CC组织和细胞系中显著上调,且TUC338的上调与淋巴结转移相关。用针对TUC338的小干扰RNA(siRNA)转染可显著抑制HeLa和C33A CC细胞系中的细胞迁移和侵袭。通过双荧光素酶报告基因检测,证实金属蛋白酶组织抑制剂1(TIMP1)在转录后水平通过3'非翻译区内的特定靶位点受到TUC338的负调控。在CC组织中也观察到TIMP1的表达与TUC338的表达呈负相关。用MigRI-TIMP1-绿色荧光蛋白过表达TIMP1可抑制CC细胞迁移和侵袭,并下调基质金属蛋白酶9,类似于TUC338 siRNA的作用。因此,本研究结果表明,TUC338通过靶向TIMP1基因并抑制CC细胞迁移和侵袭,发挥新型癌基因的作用。